Centre d'Investigation Clinique et Technologique 805
chu-poitiers.frTotal trials
75
Active
0
Phase 3
0
Total enrollment
7,616
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Neuromuscular Disease9
- Neuromuscular Diseases7
- Respiratory Failure6
- Stroke4
- Neuromuscular Disorder3
- Gait2
- Non Invasive Ventilation2
- Muscular Dystrophies2
Frequently asked questions about Centre d'Investigation Clinique et Technologique 805
- How many clinical trials does Centre d'Investigation Clinique et Technologique 805 have on ClinicalTrials.gov?
- Centre d'Investigation Clinique et Technologique 805 is listed as the lead sponsor on 75 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre d'Investigation Clinique et Technologique 805's trials are in Phase 3?
- 0 of Centre d'Investigation Clinique et Technologique 805's trials are in Phase 3.
- What therapeutic areas does Centre d'Investigation Clinique et Technologique 805 focus on?
- Centre d'Investigation Clinique et Technologique 805's most-studied conditions on ClinicalTrials.gov are Neuromuscular Disease, Neuromuscular Diseases, Respiratory Failure, Stroke, Neuromuscular Disorder.